Explore the growing trend of ADHD stimulant misuse among adults, the reasons behind recreational use, and the associated ...

Researchers have uncovered surprising evidence that anxiety may be controlled not by neurons but by two dueling groups of ...

Minnow Inhalerx hopes to be first to market with inhaled synthetic medical cannabis therapies for cancer pain and panic ...

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years.

Vagus nerve stimulation is a social-media sensation, promising instant stress relief. Here’s what the science really says ...

Psychedelics have been studied for treating AUD, but supporting controlled trials are slim. There's much more substantial evidence for naltrexone, acamprosate, and disulfiram.

A vocal minority of finasteride users speak out about the long-lasting mental side effects of the hair loss drug, as ...

The Capitol Hill battle over hemp products underscores the concerns about the increasingly wild market and the widespread ...

Although some outcomes showed small to medium effect sizes, these results must be interpreted cautiously given the presence of uncertainty factors, including considerable heterogeneity and moderate ...

A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.